Piperidine

Piperidine

SCHEMBL15511100

Br.C1CCNCC1.O=[PH](O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Piperidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
CXCR4 P61073 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA2 P00918 1/20 0.33
CHKA P35790 1/20 0.33
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperidine SCHEMBL15511101 1.00 ALDH1A1 (0.56) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Azepane SCHEMBL1450973 0.97 ALDH1A1 (0.60) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Piperidine SCHEMBL9520159 0.97 ALDH1A1 (0.60) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Pyrrolidine SCHEMBL28020245 0.97 ALDH1A1 (0.50) ALDH1A1CXCR4SMN1; SMN2
Piperidine SCHEMBL15517893 0.94 ALDH1A1 (0.56) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Azepane SCHEMBL5164365 0.94 ALDH1A1 (0.56) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Piperidine SCHEMBL15517892 0.94 ALDH1A1 (0.56) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Pyrrolidine SCHEMBL11618713 0.94 ALDH1A1 (0.53) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Piperidine SCHEMBL15570570 0.91 ALDH1A1 (0.53) ALDH1A1CXCR4SMN1; SMN2CA2CHKA
Piperidine SCHEMBL15572305 0.91 ALDH1A1 (0.53) ALDH1A1CXCR4SMN1; SMN2CA2CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104736245-B Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts 米德瑞(美国)有限公司 2017-04-12 CN claimed
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 US claimed
CN-104736245-A Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts MIDORI RENEWABLES INC 2015-06-24 CN claimed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
EP-4209130-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-12 EP disclosed
EP-4205553-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-05 EP disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-02-21 US disclosed
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE DSM NUTRITIONAL PRODUCTS, LLC 2022-12-29 US disclosed
US-20220400728-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2022-12-22 US disclosed
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF HERCULES CAPITAL, INC. 2021-11-18 US disclosed
WO-2016122885-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 WO disclosed
WO-2016122884-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 WO disclosed
WO-2016122940-A1 METHODS OF PRODUCING ANHYDROSUGAR ALCOHOLS MIDORI USA, INC. (US) 2016-08-04 WO disclosed
US-9238845-B2 Methods of producing sugars from biomass feedstocks MIDORI USA, INC. (US) 2016-01-19 US disclosed
US-20160007642-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 US disclosed
WO-2016007778-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 WO disclosed
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 US disclosed
CN-104736245-A Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts MIDORI RENEWABLES INC 2015-06-24 CN disclosed
US-20140060522-A1 METHODS OF PRODUCING SUGARS FROM BIOMASS FEEDSTOCKS HERCULES CAPITAL, INC. 2014-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC ALDH1A1 3518/4885CXCR4 3537/4885SMN1; SMN2 3680/4885
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 ALDH1A1 2641/4885CXCR4 1090/4885SMN1; SMN2 3053/4885
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC ALDH1A1 3518/4885CXCR4 3537/4885SMN1; SMN2 3680/4885
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE FUT6, FUT5, PIGS ALDH1A1 2993/4885CXCR4 3025/4885SMN1; SMN2 794/4885
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF OSTC, FUT5, FUT6 ALDH1A1 4478/4885CXCR4 3190/4885SMN1; SMN2 2253/4885
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS MGAM, CEL, SI ALDH1A1 2291/4885CXCR4 4066/4885SMN1; SMN2 3048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.